Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Entera Bio Ltd. (ENTX) vs Ovid Therapeutics (OVID)

Entera Bio Ltd. and Ovid Therapeutics are both Biotechnology companies. Entera Bio Ltd. and Ovid Therapeutics are of similar size ($487.3M and $486.7M). Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against 66.4%. Entera Bio Ltd. has the higher net margin (0.00% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 18 metrics below, Ovid Therapeutics leads on 11 and Entera Bio Ltd. on 7.

Valuation

Metric ENTX OVID Biotechnology median
P/E n/m n/m 7.88
P/S 622.15 60.33 11.47
P/B 19.09 2.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 540.72 46.84 10.73
Earnings yield (12.73%) (9.39%) (28.84%)
Free cash flow yield (7.92%) (11.59%) (23.03%)

Profitability

Metric ENTX OVID Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (742.97%) 0.00%
Net margin 0.00% (439.11%) 0.00%
Free cash flow margin 0.00% (697.30%) 0.00%
Return on equity (138.92%) (25.97%) (57.72%)
Return on assets (87.02%) (22.30%) (49.22%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric ENTX OVID Biotechnology median
Revenue growth (TTM) 66.42% 1,333.39% 5.64%
EPS growth (last fiscal year) 0.00% 37.84% —
Revenue growth, 5-year CAGR (29.19%) (10.48%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 8.98 12.39 4.73
Net debt to EBITDA 1.29 1.37 0.96

Dividend

Metric ENTX OVID Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENTX OVID Biotechnology median
Market cap 486.74m 487.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack